EDIT

Editas Medicine Inc

Jun 05 • 04:00PM ET

2.71

-0.28 -9.36 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NTLA CRSP PRME DTIL RGNX ABEO SLN VYGR MGTX SLDB

| Held by: VTI IWM VXF IWN IBB VTWO SCHA VHT IWC SCHB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.22	Insider Own	0.47%	Shs Outstand	153.46M	Perf Week	-21.68%
Market Cap	415.88M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-3.12%	Shs Float	152.74M	Perf Month	-14.65%
Enterprise Value	364.20M	PEG	-	EPS next Q	-0.27	Inst Own	46.11%	Short Float	6.26%	Perf Quarter	35.50%
Income	-108.95M	P/S	10.75	EPS this Y	44.05%	Inst Trans	0.73%	Short Ratio	4.58	Perf Half Y	14.59%
Sales	38.69M	P/B	60.17	EPS next Y	4.03%	ROA	-52.76%	Short Interest	9.56M	Perf YTD	32.20%
Book/sh	0.05	P/C	3.36	EPS next 5Y	16.43%	ROE	-326.07%	52W High	4.54 -40.27%	Perf Year	50.56%
Cash/sh	0.81	P/FCF	-	EPS past 3/5Y	17.49% 1.84%	ROIC	-175.22%	52W Low	1.66 63.25%	Perf 3Y	-71.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.15% -14.89%	Gross Margin	90.07%	Volatility	12.34% 10.78%	Perf 5Y	-91.95%
Dividend TTM	-	EV/Sales	9.41	EPS Y/Y TTM	59.82%	Oper. Margin	-230.09%	ATR (14)	0.31	Perf 10Y	-91.96%
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	7.97%	Profit Margin	-281.59%	RSI (14)	44.37	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	72.14%	SMA20	-7.62%	Beta	2.11	Target Price	5.66
Payout	-	Debt/Eq	16.32	Sales Q/Q	-39.22%	SMA50	-8.00%	Rel Volume	1.13	Prev Close	2.99
Employees	87	LT Debt/Eq	13.10	Earnings	May 05 BMO	SMA200	1.48%	Avg Volume	2.09M	Price	2.71
IPO	Feb 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.14% -55.58%	Trades		Volume	2,353,103	Change	-9.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)